{
    "name": "Giovanni Magnaghi",
    "subtitle": "CEO Zambon Spa",
    "location": "Greater Milan Metropolitan Area",
    "about": "International experienced Executive with an extensive background in Finance matured in multinational companies. Now leading Zambon organisation to continue an 118 years success story and bringing new therapeutic options to patients",
    "experiences": [
        [
            "Zambon",
            "5 yrs 6 mos",
            "CEO Zambon Spa",
            "Full-time",
            "May 2024 - Present · 1 mo",
            "Milan, Lombardy, Italy · On-site",
            "CFO Zambon Company",
            "Dec 2018 - May 2024 · 5 yrs 6 mos",
            "Milan Area, Italy"
        ],
        [
            "Gilead Sciences",
            "6 yrs 10 mos",
            "VP, Finance EMEA",
            "Sep 2016 - Nov 2018 · 2 yrs 3 mos",
            "London, United Kingdom",
            "Leading Finance function in EMEA and business partner to SVP EMEA Commercial.",
            "Regional Finance Director EMEA",
            "Aug 2013 - Aug 2016 · 3 yrs 1 mo",
            "London, United Kingdom",
            "Senior Regional Finance Director, reporting to VP Finance EMEA and Business Partner to Region VP. Managing a team of 40+ people and responsible for finance activities in 15 entities across EMEA Region. Different interim roles covered in addition: General Manager Italy (May-Sep '14), Finance Director Spain (Dec '14 - Aug '15), General Manager Turkey (Sep '15- Apr '16)",
            "Interim General Manager Turkey",
            "Sep 2015 - Apr 2016 · 8 mos",
            "Istanbul, Turkey",
            "In addition to RFD role  I have covered on an interim basis the General Manager role in the Turkish affiliate. Leadership Team reorganization, Pricing and Reimbursement negotiation, leading the organization through a transition period and strenghtening company culture while delivering continuous business growth."
        ],
        [
            "CFO - Chief Administrative Officer",
            "Henry Schein Italy",
            "May 2010 - Feb 2012 · 1 yr 10 mos",
            "Director of Finance - IT - Logistics. Managing a team of 70+ people to provide full oversight of all financial activities in Italy (Financial reporting US Gaap and Statutory - Tax - Credit Management - Financial Planning and Business Support) and coordinate IT and Logistics team."
        ],
        [
            "Bausch & Lomb EMEA",
            "11 yrs 6 mos",
            "Finance Director EMEA",
            "Jan 2009 - May 2010 · 1 yr 5 mos",
            "Finance Business Partner Vision Care EMEA and Regional Controller Italy and Spain. This Director position combines the Business Support role for EMEA region with the Controlling role of two specific countries (Italy and Spain). Managing a team of 32 people to provide excellent financial control and strategic business advice.",
            "FP&A Director EMEA",
            "Jan 2007 - Dec 2008 · 2 yrs",
            "FP&A responsibilities (Forecast and Planning, Business Ananlysis and Support) for the EMEA region",
            "Finance Director EMEA",
            "Jul 2004 - Dec 2006 · 2 yrs 6 mos",
            "Finance Responsibilities over Italy, Greece and Special Projects for EMEA region - B&amp;L Project Manager for the set up of EMEA outsourced Finance Shared Service Center"
        ],
        [
            "Financial Planning Manager",
            "Gillette Group Italy",
            "Oct 1992 - Dec 1998 · 6 yrs 3 mos",
            "Financial Planning for Grooming Division and Legal Entity"
        ]
    ],
    "posts": [
        {
            "post": "Bringing new therapeutic options to PD patients in Europe!",
            "comments": []
        },
        {
            "post": "Zcube – Zambon Research Venture is excited to announce a new edition of Open Accelerator!The 2024 call will focus on the pivotal area of women's health and will open on March 8th.Through Open Accelerator, we aim to find talented entrepreneurs whose solutions are transforming the future of women’s health. We will actively support the selected startups with investments, training, and mentoring!We reaffirm our commitment to Innovate Cure & Care to make patients’ lives better.Discover more about Open Accelerator on: https://lnkd.in/gxFehDNhashtag#openaccelerator hashtag#femtech hashtag#startup hashtag#startupcommunity hashtag#startupecosystem",
            "comments": []
        },
        {
            "post": "We are hashtag#hiring!Zambon SpA is looking for an Intern in the Strategic Planning Function.This function is currently working on the definition, elaboration, and update of the Corporate Strategy statement.Apply now and join our team!",
            "comments": []
        },
        {
            "post": "Yesterday we presented Zambon at Jefferies London Healthcare Conference 2023. This year’s gathering specifically brought together 3,000 leading executives to address near-and long-term investment opportunities as well as the current trends driving healthcare in the U.S. and internationally.hashtag#JefferiesHealthcare",
            "comments": []
        },
        {
            "post": "Super Francesca! Grateful we met, worked together and remained FRIENDS!!! You are a star ⭐️⭐️⭐️",
            "comments": []
        },
        {
            "post": "Zambon Biotech is growing!",
            "comments": []
        },
        {
            "post": "Bravo Lorenzo! Felici di averti con noi!",
            "comments": []
        },
        {
            "post": "Since 1906 we believe in the power of being hashtag#together, working united towards our vision, values and new challenges.Today we hashtag#celebrate our 116th birthday continuing to feed the breath of innovation that allows us to innovate cure and care to make patients’ lives better. Together. To get there where the future is.",
            "comments": []
        },
        {
            "post": "Great opportunity in the HQ Accounting department in Milan. Are you interested in? Submit your application to join us hashtag#Zambon!",
            "comments": []
        },
        {
            "post": "𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐍𝐞𝐰𝐬: 𝐙𝐚𝐦𝐛𝐨𝐧 𝐑𝐞𝐜𝐞𝐢𝐯𝐞𝐬 𝐔.𝐒. 𝐅𝐃𝐀 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐃𝐞𝐬𝐢𝐠𝐧𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐂𝐌𝐒 𝐈-𝐧𝐞𝐛® 𝐢𝐧 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐰𝐢𝐭𝐡 𝐍𝐨𝐧-𝐂𝐲𝐬𝐭𝐢𝐜 𝐅𝐢𝐛𝐫𝐨𝐬𝐢𝐬 𝐁𝐫𝐨𝐧𝐜𝐡𝐢𝐞𝐜𝐭𝐚𝐬𝐢𝐬 (𝐍𝐂𝐅𝐁)Zambon today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to colistimethate sodium powder for nebulization solution (CMS I-neb®) for the reduction in the incidence of pulmonary exacerbations in adult patients with non-cystic fibrosis bronchiectasis (NCFB) colonized with P. aeruginosa.Read the full news on: https://lnkd.in/dVTnC9gx",
            "comments": []
        },
        {
            "post": "Great opportunity for young talents! We wait for applications! Help us spreading the news.",
            "comments": []
        },
        {
            "post": "BREAKING NEWS! Today, during the ERS Congress we shared the positive results of the Promis-I study carried out by Zambon. We are extremely proud to be part of such an important event in Zambon's history. Our dream is coming true.hashtag#ers2021 hashtag#zambonpharma hashtag#zambonpeople",
            "comments": []
        },
        {
            "post": "Z-LIFE, nome scelto dai collaboratori Zambon ha richiesto 426 giorni di lavoro e impiegato 3.000 metri quadrati di vetro, 250mila chili di acciaio, 70 km di cavi elettrici. Rispetta i più moderni criteri di sostenibilità e prevede soluzioni tecnologicamente avanzate grazie alla gestione tramite BMS (Building Management System), un sistema che permette di monitorare e gestire tramite sensori la climatizzazione, le luci e la sicurezza dello spazio.Progetto Architettonico a cura di Michele De LucchiInterior Design a cura di Carlo RattiCredits Photos Luca Rotondo",
            "comments": []
        },
        {
            "post": "Zambon entered in an exclusive license agreement with Aquestive Therapeutics to register and commercialize riluzole Oral Film in Europe for patients with ALS (amyotrophic lateral sclerosis).“We are proud to announce that Zambon will register and commercialize in Europe riluzole Oral Film. Thanks to this partnership with Aquestive, Zambon will further strengthen its commitment to orphan diseases and to the CNS area, enriching its portfolio with a new formulation that will concretely help ALS patients. Zambon is committed to improve people’s quality of life through innovative medicines and modern therapeutic solutions where they are mostly needed,” Roberto Tascione, CEO of Zambon S.p.A.",
            "comments": []
        },
        {
            "post": "Great Conference!",
            "comments": []
        },
        {
            "post": "I joined Gilead France as Finance Director on December 1st which was also the Worldwide AIDS day.My very first contact with Gilead teams on Friday was during a morning breakfast organized around a testimony of patients living with AIDS.I have spent my whole career working for the pharmaceutical industry, but it's always very strong to be reminded why we are working...",
            "comments": []
        }
    ]
}